Clinical validity of increased cortical uptake of [(18)F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development fra...

por Wolters, E. E., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Hansson, O., Nordberg, A., Frisoni, G. B., Garibotto, V., Ossenkoppele, R.
Publicado 2021

Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study

por Wolters, E.E., van de Beek, M., Ossenkoppele, R., Golla, S.S.V., Verfaillie, S.C.J., Coomans, E.M., Timmers, T, Visser, D., Tuncel, H., Barkhof, F., Boellaard, R., Windhorst, A.D., van der Flier, W.M., Scheltens, Ph., Lemstra, A.W., van Berckel, B.N.M.
Publicado 2020